Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Moreover, a comprehensive summary of the activation strategies of the GSH system is presented, where we mainly identify several promising herbal monomers, which may provide valuable guidelines for the exploration of new therapeutic approaches
The pharmacological properties of red grape polyphenol resveratrol: Clinical trials and obstacles in drug development
However, the risk of exposure through inhalation and skin contact, especially through thermal paper is also considerable
However, mutating the two aspartic acid residues (D50A, D51A) does not impact the binding between IgM and AIM (Supplementary Fig